NASDAQ:CARA
$12.26
(
2.59%
)
Friday, 3rd Feb 2023
Cara Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $9.61 | $12.49 | Friday, 3rd Feb 2023 CARA stock ended at $12.26. This is 2.59% more than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 5.76% from a day low at $11.81 to a day high of $12.49. |
| 90 days | $8.56 | $12.81 | |
| 52 weeks | $7.40 | $13.97 |
Historical Cara Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $11.81 | $12.49 | $11.81 | $12.26 | 393 149 |
| 2023-02-02 | $11.80 | $12.10 | $11.68 | $11.95 | 262 770 |
| 2023-02-01 | $11.67 | $11.99 | $11.58 | $11.86 | 212 637 |
| 2023-01-31 | $11.09 | $12.01 | $11.09 | $11.68 | 349 726 |
| 2023-01-30 | $11.85 | $12.00 | $11.04 | $11.08 | 353 096 |
| 2023-01-27 | $12.25 | $12.44 | $11.99 | $12.00 | 237 563 |
| 2023-01-26 | $12.14 | $12.30 | $11.95 | $12.27 | 322 171 |
| 2023-01-25 | $11.58 | $12.12 | $11.47 | $12.10 | 272 143 |
| 2023-01-24 | $11.75 | $11.85 | $11.48 | $11.70 | 192 427 |
| 2023-01-23 | $11.82 | $12.01 | $11.63 | $11.82 | 228 826 |
| 2023-01-20 | $11.50 | $11.85 | $11.36 | $11.80 | 336 600 |
| 2023-01-19 | $10.86 | $11.52 | $10.82 | $11.44 | 331 700 |
| 2023-01-18 | $10.76 | $11.41 | $10.72 | $10.92 | 349 600 |
| 2023-01-17 | $10.81 | $10.82 | $10.58 | $10.72 | 360 000 |
| 2023-01-13 | $10.41 | $11.04 | $10.41 | $10.85 | 232 919 |
| 2023-01-12 | $9.84 | $10.61 | $9.61 | $10.54 | 489 300 |
| 2023-01-11 | $10.14 | $10.15 | $9.75 | $9.87 | 469 600 |
| 2023-01-10 | $9.96 | $10.35 | $9.81 | $10.15 | 661 621 |
| 2023-01-09 | $10.78 | $11.09 | $10.02 | $10.06 | 520 800 |
| 2023-01-06 | $11.14 | $11.18 | $10.61 | $10.69 | 609 700 |
| 2023-01-05 | $11.43 | $11.63 | $11.00 | $11.01 | 337 646 |
| 2023-01-04 | $11.00 | $11.49 | $10.93 | $11.44 | 257 716 |
| 2023-01-03 | $10.99 | $11.15 | $10.73 | $10.95 | 239 420 |
| 2022-12-30 | $10.91 | $11.00 | $10.56 | $10.74 | 404 269 |
| 2022-12-29 | $10.18 | $11.01 | $10.11 | $10.98 | 622 766 |
| 2022-12-28 | $9.78 | $10.20 | $9.52 | $10.11 | 373 432 |
| 2022-12-27 | $10.25 | $10.28 | $9.75 | $9.81 | 381 770 |
| 2022-12-23 | $11.04 | $11.20 | $10.20 | $10.30 | 467 432 |
| 2022-12-22 | $11.19 | $11.29 | $10.87 | $11.08 | 621 409 |
| 2022-12-21 | $11.27 | $11.47 | $11.24 | $11.30 | 255 925 |
| 2022-12-20 | $11.19 | $11.42 | $11.14 | $11.29 | 294 215 |
| 2022-12-19 | $11.46 | $11.46 | $11.10 | $11.24 | 308 197 |
| 2022-12-16 | $11.04 | $11.43 | $10.95 | $11.38 | 872 054 |
| 2022-12-15 | $11.48 | $11.49 | $11.02 | $11.17 | 382 589 |
| 2022-12-14 | $11.57 | $11.74 | $11.38 | $11.69 | 237 630 |
| 2022-12-13 | $11.82 | $11.87 | $11.38 | $11.56 | 448 419 |
| 2022-12-12 | $11.19 | $11.50 | $11.01 | $11.34 | 337 992 |
| 2022-12-09 | $12.12 | $12.22 | $11.19 | $11.24 | 340 769 |
| 2022-12-08 | $12.57 | $12.65 | $12.03 | $12.23 | 232 528 |
| 2022-12-07 | $12.25 | $12.54 | $12.24 | $12.43 | 256 735 |
| 2022-12-06 | $12.31 | $12.38 | $12.16 | $12.32 | 193 260 |
| 2022-12-05 | $12.70 | $12.80 | $12.36 | $12.49 | 416 225 |
| 2022-12-02 | $11.74 | $12.81 | $11.60 | $12.77 | 390 731 |
| 2022-12-01 | $11.79 | $11.99 | $11.57 | $11.96 | 202 901 |
| 2022-11-30 | $11.11 | $11.85 | $11.11 | $11.80 | 328 331 |
| 2022-11-29 | $11.16 | $11.24 | $10.97 | $11.02 | 247 883 |
| 2022-11-28 | $11.06 | $11.27 | $10.83 | $11.13 | 224 444 |
| 2022-11-25 | $10.93 | $11.21 | $10.74 | $11.19 | 119 583 |
| 2022-11-23 | $11.00 | $11.18 | $10.87 | $11.07 | 177 037 |
| 2022-11-22 | $10.75 | $11.05 | $10.62 | $11.01 | 245 863 |
About Cara Therapeutics
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
